Objectives: The cost-effectiveness of adding a human papillomavirus (HPV) vaccination
program in 12-year-old females to the recommended cervical cancer screening in Belgium …

Background: The objective of the present study is to evaluate the cost-effectiveness of
human papillomavirus (HPV) vaccination alongside cervical cancer screening programme in …

Objective This study aimed at evaluating the cost-effectiveness of human papillomavirus
virus (HPV) vaccination in France, using a generally applicable succinct cohort model …

Abstract Background In the Netherlands, low cervical cancer incidence and mortality rates
might limit the cost-effectiveness of vaccination against the human papillomavirus (HPV). We …

Objectives: the study aims to estimate the clinical-impact and cost-effectiveness value of
adding human papillomavirus 16/18 vaccination against cervical cancer among women …

OBJECTIVE: The study predicts long-term cervical cancer related population health and
economic effects of introducing the HPV-vaccination for 12-year-old girls (and boys) in …

We evaluated the cost‐effectiveness of HPV16/18 vaccination for girls aged 12 years in The
Netherlands in addition to cervical cancer screening. For this purpose, we developed a …

Background The cervical cancer screening program implemented in Hungary to date has
not been successful. Along with screening, vaccination is an effective intervention to prevent …

Objectives: A vaccine to prevent diseases due to human papillomavirus (HPV) types 6, 11,
16, and 18 is now available in France. The objective of this study was to assess the health …

We studied the cost-effectiveness of cervical cancer prevention strategies in the Central and
Eastern Europe and Central Asia (CEECA) region. The cost-effectiveness of human …